CRISPR Therapeutics AG (LTS:0VRQ) Dividend
CRISPR Therapeutics AG (LTS:0VRQ) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.9%. View its historical dividend record below and compare with dividend-paying peers.
Frequently Asked Questions: LTS:0VRQ Dividend
Does CRISPR Therapeutics AG (LTS:0VRQ) pay a dividend?
CRISPR Therapeutics AG (LTS:0VRQ) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.
Why doesn't CRISPR Therapeutics AG pay a dividend?
Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. CRISPR Therapeutics AG has returned capital to shareholders via buybacks at a rate of -6.9% over the past 3 years.
What are dividend-paying alternatives to CRISPR Therapeutics AG?
For dividend-paying alternatives in CRISPR Therapeutics AG's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.